Time course of the interaction between tadalafil and nitrates

被引:108
作者
Kloner, RA
Hutter, AM
Emmick, JT
Mitchell, MI
Denne, J
Jackson, G
机构
[1] Univ So Calif, Keck Sch Med, Good Samaritan Hosp, Heart Inst,Cardiovasc Div, Los Angeles, CA 90017 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Erl Wood Manor, Surrey, England
[5] Guys & St Thomas Hosp, London SE1 9RT, England
关键词
D O I
10.1016/j.jacc.2003.09.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study was designed to determine the time course of nitrate interaction with tadalafil, a phosphodiesterase 5 (PDE5) inhibitor with a half-life (t(1/2)) of 17.5 h. BACKGROUND The PDE5 inhibitors augment the blood pressure (BP)-lowering effects of nitrates, yet the time course of this interaction is unclear. Recent guidelines from the American College of Cardiology/American Heart Association recommend that nitrates be withheld for 24 h after taking sildenafil (t(1/2) = 4 h). METHODS Male subjects (n = 150) received seven consecutive daily doses of placebo or tadalafil (20 mg). On day 7 and beyond, subjects received repeated doses of sublingual nitroglycerin (0.4 mg) after the last dose of placebo or tadalafil. After a 10- to 21-day washout period, subjects crossed over to either placebo or tadalafil, and nitrate dosing was repeated. RESULTS In response to nitroglycerin at 4, 8, and 24 h, standing systolic BP fell below 85 mm Hg in more subjects on tadalafil compared with placebo (p < 0.05), with no difference in the response to nitroglycerin at 48, 72, and 96 h (p > 0.2). Similar observations were made for standing diastolic BP <45 mm Hg, decrease in systolic BP >30 mm Hg, and decrease in diastolic BP >20 mm Hg. Nitroglycerin also evoked greater mean maximal decreases in standing systolic BP at 8 and 24 h after taking tadalafil versus placebo (p < 0.02), with no significant difference at 48, 72, or 96 h (p > 0.49). CONCLUSIONS The hemodynamic interaction between tadalafil and sublingual nitroglycerin lasted 24 h, but was not seen at 48 h and beyond. Similar to other PDE5 inhibitors, tadalafil should not be administered in combination with organic nitrates. (C) 2003 by the American College of Cardiology Foundation.
引用
收藏
页码:1855 / 1860
页数:6
相关论文
共 11 条
  • [1] CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES - FUNCTIONAL IMPLICATIONS OF MULTIPLE ISOFORMS
    BEAVO, JA
    [J]. PHYSIOLOGICAL REVIEWS, 1995, 75 (04) : 725 - 748
  • [2] Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses
    Brock, GB
    McMahon, CG
    Chen, KK
    Costigan, T
    Shen, W
    Watkins, V
    Anglin, G
    Whitaker, S
    [J]. JOURNAL OF UROLOGY, 2002, 168 (04) : 1332 - 1336
  • [3] BROWN H, 1999, APPL MIXED MODELS ME, P261
  • [4] Use of sildenafil (Viagra) in patients with cardiovascular disease
    Cheitlin, MD
    Hutter, AM
    Brindis, RG
    Ganz, P
    Kaul, S
    Russell, RO
    Zusman, RM
    Forrester, JS
    Douglas, PS
    Faxon, DP
    Fisher, JD
    Gibbons, RJ
    Halperin, JL
    Hochman, JS
    Kaul, S
    Weintraub, WS
    Winters, WL
    Wolk, MJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) : 273 - 282
  • [5] Overview of the cardiovascular effects of tadalafil
    Emmick, JT
    Stuewe, SR
    Mitchell, M
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2002, 4 (0H) : H32 - H47
  • [6] Oral sildenafil in the treatment of erectile dysfunction
    Goldstein, I
    Lue, TF
    Padma-Nathan, H
    Rosen, RC
    Steers, WD
    Wicker, PA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) : 1397 - 1404
  • [7] Kloner RA, 1999, AM J CARDIOL, V83, P576
  • [8] Kloner Robert A., 2000, American Journal of Medicine, V109, p13S
  • [9] Prescott R. J., 1981, Applied Statistics, V30, P9, DOI 10.2307/2346652
  • [10] Webb DJ, 1999, AM J CARDIOL, V83, p21C